In contrast, inhibiting SPRY4 increased the protein level of β3-integrin, which promotes cell migration and invasion in vitro and lung metastasis in vivo in breast cancer cells (36, 90, 91). The gene discussed is SPRY4; the disease is breast carcinoma.